Biden's Medicare Plan Sparks Debate Over Weight-Loss Drug Coverage

The Biden administration is pushing to expand Medicare coverage for anti-obesity drugs, a move that could benefit millions of seniors but faces potential opposition from the incoming Trump administration due to high costs. The proposal aims to address obesity as a chronic condition, potentially impacting broader access to these drugs. However, the financial implications and political dynamics, including possible legal challenges, make the future of this initiative uncertain.